LT3113B - Novel phospholipide derivatives - Google Patents

Novel phospholipide derivatives Download PDF

Info

Publication number: LT3113B
Authority: LT; Lithuania
Prior art keywords: compounds; phosphate; pharmaceutical composition; composition according; mmol
Prior art date: 1992-07-11

Application number

LTIP620A

Other languages

English (en)

Lithuanian (lt)

Inventor

Gerhard Nossner

Bernhard Kutscher

Juergen Engel

Wolfgang Schumacher

Jurij Stekar

Peter Hilgard

Original Assignee

Asta Medica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-11

Filing date

1993-06-04

Publication date

1994-12-27

1993-06-04 Application filed by Asta Medica Ag filed Critical Asta Medica Ag

1994-07-15 Publication of LTIP620A publication Critical patent/LTIP620A/xx

1994-12-27 Publication of LT3113B publication Critical patent/LT3113B/lt

Links

238000002360 preparation method Methods 0.000 claims abstract description 10
229910019142 PO4 Inorganic materials 0.000 claims description 30
239000010452 phosphate Substances 0.000 claims description 30
238000000034 method Methods 0.000 claims description 28
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 25
239000000203 mixture Substances 0.000 claims description 24
150000001875 compounds Chemical class 0.000 claims description 22
239000002904 solvent Substances 0.000 claims description 21
125000004432 carbon atom Chemical group C* 0.000 claims description 14
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 14
150000002500 ions Chemical class 0.000 claims description 12
239000008194 pharmaceutical composition Substances 0.000 claims description 12
229910052698 phosphorus Inorganic materials 0.000 claims description 8
150000003839 salts Chemical class 0.000 claims description 7
230000002378 acidificating effect Effects 0.000 claims description 6
239000004480 active ingredient Substances 0.000 claims description 5
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
229910052739 hydrogen Inorganic materials 0.000 claims description 4
239000001257 hydrogen Substances 0.000 claims description 4
238000000746 purification Methods 0.000 claims description 4
229920006395 saturated elastomer Polymers 0.000 claims description 4
125000000217 alkyl group Chemical group 0.000 claims description 3
125000004122 cyclic group Chemical group 0.000 claims description 3
229910052717 sulfur Inorganic materials 0.000 claims description 3
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
239000002168 alkylating agent Substances 0.000 claims description 2
229940100198 alkylating agent Drugs 0.000 claims description 2
239000000460 chlorine Substances 0.000 claims description 2
229910052801 chlorine Inorganic materials 0.000 claims description 2
125000004430 oxygen atom Chemical group O* 0.000 claims description 2
229910052760 oxygen Inorganic materials 0.000 claims 3
239000001301 oxygen Substances 0.000 claims 3
239000000546 pharmaceutical excipient Substances 0.000 claims 3
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
210000001185 bone marrow Anatomy 0.000 claims 2
239000003937 drug carrier Substances 0.000 claims 2
125000004434 sulfur atom Chemical group 0.000 claims 2
208000030507 AIDS Diseases 0.000 claims 1
208000023275 Autoimmune disease Diseases 0.000 claims 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
208000004554 Leishmaniasis Diseases 0.000 claims 1
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
208000031888 Mycoses Diseases 0.000 claims 1
206010028980 Neoplasm Diseases 0.000 claims 1
201000004681 Psoriasis Diseases 0.000 claims 1
239000013543 active substance Substances 0.000 claims 1
239000002246 antineoplastic agent Substances 0.000 claims 1
229940041181 antineoplastic drug Drugs 0.000 claims 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
229910052794 bromium Inorganic materials 0.000 claims 1
239000003795 chemical substances by application Substances 0.000 claims 1
239000000824 cytostatic agent Substances 0.000 claims 1
230000001085 cytostatic effect Effects 0.000 claims 1
230000006378 damage Effects 0.000 claims 1
201000010099 disease Diseases 0.000 claims 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
239000000945 filler Substances 0.000 claims 1
150000004820 halides Chemical class 0.000 claims 1
208000027866 inflammatory disease Diseases 0.000 claims 1
230000002757 inflammatory effect Effects 0.000 claims 1
230000003902 lesion Effects 0.000 claims 1
150000002632 lipids Chemical class 0.000 claims 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
239000012046 mixed solvent Substances 0.000 claims 1
201000006417 multiple sclerosis Diseases 0.000 claims 1
239000003960 organic solvent Substances 0.000 claims 1
125000004437 phosphorous atom Chemical group 0.000 claims 1
208000017520 skin disease Diseases 0.000 claims 1
238000002560 therapeutic procedure Methods 0.000 claims 1
230000003612 virological effect Effects 0.000 claims 1
150000003904 phospholipids Chemical class 0.000 abstract description 2
239000003814 drug Substances 0.000 abstract 1
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 117
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 61
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 54
XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 49
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 44
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 38
229910021529 ammonia Inorganic materials 0.000 description 29
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 26
239000010410 layer Substances 0.000 description 20
239000000047 product Substances 0.000 description 19
239000000243 solution Substances 0.000 description 19
GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 18
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 16
-1 acyclic ethers Chemical class 0.000 description 16
239000002585 base Substances 0.000 description 16
ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 15
238000004458 analytical method Methods 0.000 description 15
238000006243 chemical reaction Methods 0.000 description 15
238000003756 stirring Methods 0.000 description 15
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 14
239000001632 sodium acetate Substances 0.000 description 14
229960004249 sodium acetate Drugs 0.000 description 14
235000017281 sodium acetate Nutrition 0.000 description 14
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 11
239000000463 material Substances 0.000 description 10
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
229920001429 chelating resin Polymers 0.000 description 8
238000000921 elemental analysis Methods 0.000 description 8
239000000741 silica gel Substances 0.000 description 8
229910002027 silica gel Inorganic materials 0.000 description 8
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 7
239000002253 acid Substances 0.000 description 7
239000011574 phosphorus Substances 0.000 description 7
239000011541 reaction mixture Substances 0.000 description 7
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
150000001298 alcohols Chemical class 0.000 description 6
150000004945 aromatic hydrocarbons Chemical class 0.000 description 6
BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
239000003480 eluent Substances 0.000 description 5
239000011734 sodium Substances 0.000 description 5
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
239000000706 filtrate Substances 0.000 description 4
150000008282 halocarbons Chemical class 0.000 description 4
229930195733 hydrocarbon Natural products 0.000 description 4
239000007788 liquid Substances 0.000 description 4
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
229910052708 sodium Inorganic materials 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
229910000147 aluminium phosphate Inorganic materials 0.000 description 3
230000000259 anti-tumor effect Effects 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
150000004292 cyclic ethers Chemical class 0.000 description 3
VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 3
238000004090 dissolution Methods 0.000 description 3
150000002170 ethers Chemical class 0.000 description 3
150000002430 hydrocarbons Chemical class 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
239000012044 organic layer Substances 0.000 description 3
238000010992 reflux Methods 0.000 description 3
229930195734 saturated hydrocarbon Natural products 0.000 description 3
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
239000010409 thin film Substances 0.000 description 3
BTANRVKWQNVYAZ-SCSAIBSYSA-N (2R)-butan-2-ol Chemical compound CC[C@@H](C)O BTANRVKWQNVYAZ-SCSAIBSYSA-N 0.000 description 2
SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
229910052784 alkaline earth metal Inorganic materials 0.000 description 2
150000001414 amino alcohols Chemical class 0.000 description 2
230000000843 anti-fungal effect Effects 0.000 description 2
238000009835 boiling Methods 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
238000001816 cooling Methods 0.000 description 2
MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 description 2
238000003818 flash chromatography Methods 0.000 description 2
229910052736 halogen Inorganic materials 0.000 description 2
150000002367 halogens Chemical class 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
239000011707 mineral Substances 0.000 description 2
235000010755 mineral Nutrition 0.000 description 2
229910000027 potassium carbonate Inorganic materials 0.000 description 2
238000010898 silica gel chromatography Methods 0.000 description 2
229910000029 sodium carbonate Inorganic materials 0.000 description 2
HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
238000004809 thin layer chromatography Methods 0.000 description 2
WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 1
TVIVIMTXHOLYOB-UHFFFAOYSA-N (1-methylpiperidin-1-ium-4-yl) octadecyl phosphate Chemical compound CCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[NH+](C)CC1 TVIVIMTXHOLYOB-UHFFFAOYSA-N 0.000 description 1
DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
BAUWRHPMUVYFOD-UHFFFAOYSA-N 1-methylpiperidin-4-ol Chemical compound CN1CCC(O)CC1 BAUWRHPMUVYFOD-UHFFFAOYSA-N 0.000 description 1
125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
235000021537 Beetroot Nutrition 0.000 description 1
GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
235000005979 Citrus limon Nutrition 0.000 description 1
244000131522 Citrus pyriformis Species 0.000 description 1
XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
102000006835 Lamins Human genes 0.000 description 1
108010047294 Lamins Proteins 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
241000218225 Trema Species 0.000 description 1
239000003929 acidic solution Substances 0.000 description 1
239000003463 adsorbent Substances 0.000 description 1
150000001338 aliphatic hydrocarbons Chemical group 0.000 description 1
239000003513 alkali Substances 0.000 description 1
229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
150000008041 alkali metal carbonates Chemical class 0.000 description 1
150000004996 alkyl benzenes Chemical class 0.000 description 1
230000029936 alkylation Effects 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
229940095054 ammoniac Drugs 0.000 description 1
235000011114 ammonium hydroxide Nutrition 0.000 description 1
150000003863 ammonium salts Chemical class 0.000 description 1
BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
125000004429 atom Chemical group 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
125000001309 chloro group Chemical group Cl* 0.000 description 1
MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000012043 crude product Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
239000002178 crystalline material Substances 0.000 description 1
125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
229940117389 dichlorobenzene Drugs 0.000 description 1
150000005690 diesters Chemical class 0.000 description 1
SDIXRDNYIMOKSG-UHFFFAOYSA-L disodium methyl arsenate Chemical compound [Na+].[Na+].C[As]([O-])([O-])=O SDIXRDNYIMOKSG-UHFFFAOYSA-L 0.000 description 1
238000001035 drying Methods 0.000 description 1
ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000011010 flushing procedure Methods 0.000 description 1
239000006260 foam Substances 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
238000005213 imbibition Methods 0.000 description 1
239000012442 inert solvent Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
210000005053 lamin Anatomy 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
VUQUOGPMUUJORT-UHFFFAOYSA-N methyl 4-methylbenzenesulfonate Chemical compound COS(=O)(=O)C1=CC=C(C)C=C1 VUQUOGPMUUJORT-UHFFFAOYSA-N 0.000 description 1
CAAULPUQFIIOTL-UHFFFAOYSA-N methyl dihydrogen phosphate Chemical compound COP(O)(O)=O CAAULPUQFIIOTL-UHFFFAOYSA-N 0.000 description 1
GBIXPTZKRXWEDI-UHFFFAOYSA-N methyl hydrogen sulfate;toluene Chemical compound COS(O)(=O)=O.CC1=CC=CC=C1 GBIXPTZKRXWEDI-UHFFFAOYSA-N 0.000 description 1
238000002156 mixing Methods 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
239000012074 organic phase Substances 0.000 description 1
125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
HDOWRFHMPULYOA-UHFFFAOYSA-N piperidin-4-ol Chemical compound OC1CCNCC1 HDOWRFHMPULYOA-UHFFFAOYSA-N 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
150000003248 quinolines Chemical group 0.000 description 1
238000001953 recrystallisation Methods 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
229940082707 skyla Drugs 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
238000000935 solvent evaporation Methods 0.000 description 1
239000007921 spray Substances 0.000 description 1
125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
239000000052 vinegar Substances 0.000 description 1
235000021419 vinegar Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/10—Phosphatides, e.g. lecithin
- C07F9/106—Adducts, complexes, salts of phosphatides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/5532—Seven-(or more) membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Immunology (AREA)
AIDS & HIV (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Inorganic Compounds Of Heavy Metals (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

LTIP620A 1992-07-11 1993-06-04 Novel phospholipide derivatives LT3113B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4222910A DE4222910A1 (de)	1992-07-11	1992-07-11	Neue Phospholipidderivate

Publications (2)

Publication Number	Publication Date
LTIP620A LTIP620A (en)	1994-07-15
LT3113B true LT3113B (en)	1994-12-27

Family

ID=6463031

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LTIP620A LT3113B (en)	1992-07-11	1993-06-04	Novel phospholipide derivatives

Country Status (31)

Country	Link
EP (1)	EP0579939B1 (fr)
JP (1)	JP3311431B2 (fr)
KR (1)	KR100297180B1 (fr)
CN (1)	CN1039012C (fr)
AT (1)	ATE176477T1 (fr)
AU (1)	AU664101B2 (fr)
BR (1)	BR9302809A (fr)
CA (2)	CA2100228C (fr)
CZ (1)	CZ290863B6 (fr)
DE (2)	DE4222910A1 (fr)
DK (1)	DK0579939T3 (fr)
EE (1)	EE03140B1 (fr)
ES (1)	ES2129053T3 (fr)
FI (1)	FI111262B (fr)
GR (1)	GR3029602T3 (fr)
HR (1)	HRP931046B1 (fr)
HU (1)	HU218783B (fr)
IL (1)	IL106289A (fr)
LT (1)	LT3113B (fr)
LV (1)	LV10870B (fr)
MX (1)	MX9304133A (fr)
NO (1)	NO306468B1 (fr)
PL (3)	PL173388B1 (fr)
RU (1)	RU2108336C1 (fr)
SG (1)	SG46249A1 (fr)
SI (1)	SI9300365B (fr)
SK (1)	SK283827B6 (fr)
TW (1)	TW304956B (fr)
UA (1)	UA40567C2 (fr)
YU (1)	YU49079B (fr)
ZA (1)	ZA934971B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101146532B (zh)	2005-01-21	2012-05-09	阿斯泰克斯治疗有限公司	药物化合物
EP1962862B1 (fr)	2005-12-19	2013-09-04	Æterna Zentaris GmbH	Nouveaux alkylphospholipides et leur utilisation
EP1800684A1 (fr) *	2005-12-20	2007-06-27	Zentaris GmbH	Nouveaux alkylphospholipides et leur utilisation
EP1869981A1 (fr) *	2006-06-21	2007-12-26	Staatliches Weinbauinstitut Freiburg	Alkylphospholipides et lysophospholipides pour la lutte contre les phytopathogènes
EP2073807A1 (fr)	2006-10-12	2009-07-01	Astex Therapeutics Limited	Combinaisons pharmaceutiques
WO2008044041A1 (fr)	2006-10-12	2008-04-17	Astex Therapeutics Limited	Combinaisons pharmaceutiques

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0108565A2 (fr)	1982-11-08	1984-05-16	Takeda Chemical Industries, Ltd.	Phospholipides, leur production et leur utilisation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0050327B1 (fr) *	1980-10-21	1984-06-20	Roche Diagnostics GmbH	Phospholipides contenant du soufre, leur procédé de préparation et médicaments contenant ces composés
DE3530767A1 (de) *	1985-08-28	1987-03-12	Max Planck Gesellschaft	Mittel gegen multiple sklerose
IE59777B1 (en) *	1985-12-04	1994-04-06	Max Planck Gesellschaft	Medicaments
ES2036210T3 (es) *	1986-07-14	1993-05-16	Nippon Chemiphar Co., Ltd.	Un procedimiento para la preparacion de un derivado de glicerol.
EP0284395B1 (fr) *	1987-03-24	1993-06-23	Nippon Chemiphar Co., Ltd.	Dérives du glycérol et agent antihypertensif
DE3906952A1 (de) *	1989-03-04	1990-09-06	Boehringer Mannheim Gmbh	(3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel
DE3942933A1 (de) *	1989-12-23	1991-06-27	Boehringer Mannheim Gmbh	Verwendung von alkylphospholipiden als antivirale arzneimittel und neue phospholipid-derivate
DE4114586A1 (de) *	1991-05-04	1992-11-05	Boehringer Mannheim Gmbh	Arzneimittel enthaltend azacyclodiphosphonsaeurederivate, neue azacyclodiphosphonsaeurederivate sowie verfahren zu deren herstellung

1992
- 1992-07-11 DE DE4222910A patent/DE4222910A1/de not_active Ceased
1993
- 1993-06-01 TW TW082104345A patent/TW304956B/zh not_active IP Right Cessation
- 1993-06-03 SG SG1996001626A patent/SG46249A1/en unknown
- 1993-06-03 DK DK93108904T patent/DK0579939T3/da active
- 1993-06-03 ES ES93108904T patent/ES2129053T3/es not_active Expired - Lifetime
- 1993-06-03 DE DE59309355T patent/DE59309355D1/de not_active Expired - Lifetime
- 1993-06-03 EP EP93108904A patent/EP0579939B1/fr not_active Expired - Lifetime
- 1993-06-03 AT AT93108904T patent/ATE176477T1/de active
- 1993-06-04 LT LTIP620A patent/LT3113B/lt not_active IP Right Cessation
- 1993-06-23 CZ CZ19931249A patent/CZ290863B6/cs not_active IP Right Cessation
- 1993-06-28 SK SK670-93A patent/SK283827B6/sk not_active IP Right Cessation
- 1993-07-06 YU YU47393A patent/YU49079B/sh unknown
- 1993-07-08 PL PL93299624A patent/PL173388B1/pl unknown
- 1993-07-08 PL PL93318680A patent/PL175607B1/pl unknown
- 1993-07-08 NO NO932502A patent/NO306468B1/no not_active IP Right Cessation
- 1993-07-08 JP JP16911493A patent/JP3311431B2/ja not_active Expired - Lifetime
- 1993-07-08 PL PL93318679A patent/PL177811B1/pl unknown
- 1993-07-09 CA CA002100228A patent/CA2100228C/fr not_active Expired - Lifetime
- 1993-07-09 CA CA002511753A patent/CA2511753C/fr not_active Expired - Lifetime
- 1993-07-09 BR BR9302809A patent/BR9302809A/pt not_active Application Discontinuation
- 1993-07-09 SI SI9300365A patent/SI9300365B/sl unknown
- 1993-07-09 UA UA93002052A patent/UA40567C2/uk unknown
- 1993-07-09 ZA ZA934971A patent/ZA934971B/xx unknown
- 1993-07-09 IL IL10628993A patent/IL106289A/xx not_active IP Right Cessation
- 1993-07-09 AU AU41864/93A patent/AU664101B2/en not_active Expired
- 1993-07-09 MX MX9304133A patent/MX9304133A/es active IP Right Grant
- 1993-07-09 HU HU9301992A patent/HU218783B/hu unknown
- 1993-07-09 FI FI933165A patent/FI111262B/fi not_active IP Right Cessation
- 1993-07-09 HR HR931046A patent/HRP931046B1/xx not_active IP Right Cessation
- 1993-07-09 RU RU93047049A patent/RU2108336C1/ru active
- 1993-07-10 KR KR1019930012980A patent/KR100297180B1/ko not_active Expired - Lifetime
- 1993-07-10 CN CN93108564A patent/CN1039012C/zh not_active Expired - Lifetime
- 1993-07-12 LV LVP-93-988A patent/LV10870B/lv unknown
1994
- 1994-10-25 EE EE9400199A patent/EE03140B1/xx unknown
1999
- 1999-03-08 GR GR990400689T patent/GR3029602T3/el unknown

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0108565A2 (fr)	1982-11-08	1984-05-16	Takeda Chemical Industries, Ltd.	Phospholipides, leur production et leur utilisation

Also Published As

Publication number	Publication date
LTIP620A (en)	1994-07-15
CA2100228A1 (fr)	1994-01-12
PL173388B1 (pl)	1998-02-27
RU2108336C1 (ru)	1998-04-10
CA2100228C (fr)	2006-01-24
EE03140B1 (et)	1998-12-15
SI9300365A (en)	1994-03-31
FI933165A7 (fi)	1994-01-12
ATE176477T1 (de)	1999-02-15
YU49079B (sh)	2003-08-29
SG46249A1 (en)	1998-02-20
IL106289A (en)	2000-06-01
KR940002265A (ko)	1994-02-17
CZ290863B6 (cs)	2002-11-13
CZ124993A3 (en)	1995-03-15
ZA934971B (en)	1994-02-01
NO932502D0 (no)	1993-07-08
EP0579939B1 (fr)	1999-02-03
PL177811B1 (pl)	2000-01-31
IL106289A0 (en)	1994-04-12
HU9301992D0 (en)	1993-09-28
DE4222910A1 (de)	1994-01-13
DK0579939T3 (da)	1999-09-20
CN1084175A (zh)	1994-03-23
CA2511753C (fr)	2007-09-25
HRP931046B1 (en)	2000-06-30
PL299624A1 (en)	1994-02-21
CA2511753A1 (fr)	1994-01-12
LV10870A (lv)	1995-10-20
AU4186493A (en)	1994-01-13
JP3311431B2 (ja)	2002-08-05
ES2129053T3 (es)	1999-06-01
SK283827B6 (sk)	2004-02-03
FI933165A0 (fi)	1993-07-09
SK67093A3 (en)	1995-03-08
PL175607B1 (pl)	1999-01-29
FI111262B (fi)	2003-06-30
LV10870B (en)	1996-06-20
AU664101B2 (en)	1995-11-02
MX9304133A (es)	1994-04-29
BR9302809A (pt)	1994-03-15
KR100297180B1 (ko)	2001-11-30
HU218783B (hu)	2000-12-28
NO306468B1 (no)	1999-11-08
EP0579939A1 (fr)	1994-01-26
CN1039012C (zh)	1998-07-08
HRP931046A2 (en)	1997-04-30
JPH0733791A (ja)	1995-02-03
HUT64548A (en)	1994-01-28
DE59309355D1 (de)	1999-03-18
GR3029602T3 (en)	1999-06-30
YU47393A (sh)	1997-08-22
SI9300365B (sl)	2002-02-28
TW304956B (fr)	1997-05-11
UA40567C2 (uk)	2001-08-15
NO932502L (no)	1994-01-12

Legal Events

Date	Code	Title	Description
2002-04-25	PC9A	Transfer of patents	Free format text: 20020306 * ZENTARIS AG,DE
2005-04-25	PD9A	Change of patent owner	Owner name: ZENTARIS GMBH, DE Effective date: 20050222
2006-07-25	PD9A	Change of patent owner	Owner name: ZENTARIS GMBH, DE Effective date: 20060605
2006-07-25	TC9A	Change of representative	Owner name: ZENTARIS GMBH, DE
2013-07-25	MK9A	Expiry of a patent	Effective date: 20130604

Publication	Publication Date	Title
SU1087052A3 (ru)	1984-04-15	Рентгеноконтрастное средство
ZA200300168B (en)	2004-07-07	3'-Prodrugs of 2'-deoxy-beta-L-nucleosides.
DK167808B1 (da)	1993-12-20	Methylen-bisphosphonsyrederivat, fremgangsmaade til fremstilling heraf samt farmaceutisk sammensaetning indeholdende disse derivater
JPH08502287A (ja)	1996-03-12	抗炎症剤としてのピリミジンビスホスホン酸エステルおよび（アルコキシメチルホスフィニル）アルキルホスホン酸
PT93724A (pt)	1990-11-20	Processo para a preparacao de compostos contendo fosforo
LT3113B (en)	1994-12-27	Novel phospholipide derivatives
US20110212923A1 (en)	2011-09-01	Phosphate Derivatives of Substituted Benzoxazoles
EP0328111A2 (fr)	1989-08-16	Inhibiteurs de métastase de cellules cancéreuses
US5155099A (en)	1992-10-13	Alkylphosphonoserines and pharmaceutical compositions useful as cytostatic agents
CA2266051A1 (fr)	1998-03-19	Derives d'oestrariene a trisubstitution-d-homo-1,3,5,(10)
RU2247125C2 (ru)	2005-02-27	Конъюгаты 4-бензиламинохинолинов с желчной кислотой и их гетероаналоги, способ их получения и лекарственные средства на основе этих соединений
US5405994A (en)	1995-04-11	Disodium 4-chlorophenylthiomethylenebisphosphonate monohydrate, its preparation and pharmaceutical compositions in which it is present
US5215972A (en)	1993-06-01	Steroids
US6172050B1 (en)	2001-01-09	Phospholipid derivatives
JP3176720B2 (ja)	2001-06-18	抗新生物作用を有する薬剤、オクタデシル−［２−（ｎ−メチルピペリジノ）−エチル］−ホスフェートの製造及び精製法及び薬剤の製法
JPS5929647A (ja)	1984-02-16	Ｎ−Ｌ−α−アスパルチル−Ｌ−フエニルアラニンの低級アルキルエステルの製造法及びこれを製造するための中間生成物
EP1385858B1 (fr)	2006-04-12	Nouveaux derives 5-thio-ss-d-xylopyranosides, procede de preparation, compositions pharmaceutiques les contenant et leur utilisation en therapeutique
RU2126413C1 (ru)	1999-02-20	Производные фосфолипидов, способ их получения, фармацевтическая композиция на их основе и способ получения фармацевтической композиции
DK149026B (da)	1985-12-23	Analogifremgangsmaade til fremstilling af adeninnucleosidderivater
EP0121635A1 (fr)	1984-10-17	3',5'-Diarabinosides, leur préparation et leur application en thérapeutique
EP1448576B1 (fr)	2005-06-15	Preparation de polymorphes cristallins de fosinopril sodium
CA2159776C (fr)	2007-04-24	Acides imidobisphosphoriques; methode de preparation et utilisation
CA2085520C (fr)	1996-07-16	Hexahydrate stable d'etoposide-4'-phosphate, sel disodique
AU750407B2 (en)	2002-07-18	Prodrugs of phosphorous-containing pharmaceuticals
Kuszmann et al.	1966	Synthesis of new sugar derivatives having potential antitumour activity: Part IX. Cyclic phosphoric acid derivatives